Supplemental material
Human Vaccines & Immunotherapeutics
Volume 17, 2021 - Issue 6
Research Paper
Risk factors for invasive meningococcal disease: a retrospective analysis of the French national public health insurance database
Muhamed-Kheir Tahaa Invasive Bacterial Infections Unit, Institut Pasteur, Paris, France
https://orcid.org/0000-0002-0716-3174View further author information
https://orcid.org/0000-0002-0716-3174View further author information, Catherine Weil-Olivierb Service de Pédiatrie, Université de Paris VII Diderot, Paris, Francehttps://orcid.org/0000-0001-5271-1945View further author information
https://orcid.org/0000-0001-5271-1945View further author information, Stéphane Bouéec RWE Department, CEMKA-EVAL, Bourg-la-Reine, Francehttps://orcid.org/0000-0001-6838-2680View further author information
https://orcid.org/0000-0001-6838-2680View further author information, Corinne Emeryc RWE Department, CEMKA-EVAL, Bourg-la-Reine, Francehttps://orcid.org/0000-0002-7333-0567View further author information
https://orcid.org/0000-0002-7333-0567View further author information, Gaëlle Nachbaurd Vaccine Medical Department, GSK, Rueil-Malmaison, Francehttps://orcid.org/0000-0001-5116-0723View further author information
https://orcid.org/0000-0001-5116-0723View further author information, Céline Pribild Vaccine Medical Department, GSK, Rueil-Malmaison, Francehttps://orcid.org/0000-0002-3126-0572View further author information
https://orcid.org/0000-0002-3126-0572View further author information & Véronique Loncle-Provotd Vaccine Medical Department, GSK, Rueil-Malmaison, FranceCorrespondence[email protected]
https://orcid.org/0000-0002-6397-7922View further author information
https://orcid.org/0000-0002-6397-7922View further author information show all